狠狠色丁香婷婷综合久小说久,国产亚洲精品第一综合另类 ,亚洲av无码精品色午夜飞机馆,国产无套码AⅤ在线观看

Chelsea Therapeutics   
Chelsea Therapeutics International Ltd.是生技制藥公司，從事類風濕性關節(jié)炎、牛皮癬、癌癥及其它免疫系統(tǒng)混亂的治療用藥。該公司重點研究中的新藥CH-1504，則是一種口服型的消炎、抗癌藥物

 
Chelsea Therapeutics (Nasdaq:CHTP) is a biopharmaceutical development company that acquires and develops innovative products for the treatment of a variety of human diseases, including central nervous system disorders. Chelsea is currently pursuing FDA approval in the U.S. for Northera? (droxidopa), a novel, late-stage, orally-active therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension in patients with primary autonomic failure.